Single dose H1N1 vaccines get FDA OK
The FDA has approved four vaccines for the H1N1 influenza virus, while other companies, including UK pharma giant GlaxoSmithKline (GSK), have reported promising results from clinical studies with a single dose vaccine. More...
Eli Lilly reorganizes and cuts 5500 jobs
Eli Lilly and Co. is undergoing a company-wide reorganization intended to accelerate the progress of the company’s pipeline. More...
FDA assumes role of public health agency
After introducing the concept of the FDA as a public health agency earlier this year with FDA Commissioner Margaret Hamburg, the FDA's Principal Deputy Commissioner, Joshua M. Sharfstein, has now outlined four principles that define the agency's role. More...
Current pharma model irrelevant
The current pharmaceutical model is in danger of becoming "irrelevant in the context of 21st century's global healthcare needs", according to a white paper published by global management consultancy firm A.T. Kearney. More...
Developing flow chemistry for pharma
AM Technology (UK) has joined an EU-funded project that seeks to develop flow processes for the industrial synthesis of pharmaceutical compounds. More...
Join PTE on LinkedIn!
Join Pharmaceutical Technology Europe's group on LinkedIn. More...
Scientists discover RNA interference in budding yeast
Vaccine makers and other pharmaceutical manufacturers using yeast protein-expression systems are taking note of a discovery this week by a team of researchers who have found RNA interference in Saccharomyces castellii. More...
A step-by-step path to effective product complaint management
Product failure can be potentially fatal to a customer and have severe implications for manufacturers; however, many pharma companies still believe that complaint management is not related to the overall management of customer relationships. More...
| |
Property Measurement and Testing of Powders for Pharmaceutical/Neutraceutical Production
29 September 2009
UK
A one-day seminar hosted by the University of Greenwich focusing on the practicalities of achieving and maintaining production of high quality products whilst minimising the generation of out-of specification materials.
 Read more...
|
|
|
|
|
| |
|
| |
| Latest peer-reviewed research |
|
|
|
